Table 2.
Author | Samples | Location | Mesh | Perioperative complications | Median follow‐up mo (range) | Recurrence | Re‐revision |
---|---|---|---|---|---|---|---|
Crespin et al54 | 16 | Right: 12 | Biologic | None | 9 (6‐83) | 6 (50%) | 0 |
Left: 3 | 2 (67%) | 2 (67%) | |||||
Bilateral:1 | 1 (100%) | 0 | |||||
Greene et al55 | 15 | Right: 13 | Biologic:10 Synthetic:5 | None | 15 (1‐27) | 1 (7%, location is unknown) | 0 |
Left: 1 | |||||||
Bilateral:1 | |||||||
Alicuben et al56 | 10 | Right: 8 | Biologic | N/A | 5 (unknown) | 1 (13%) | 0 |
Left: 1 | 0 | ||||||
Bilateral:1 | 0 | ||||||
Yano et al57 | 5 | Left: 5 | Synthetic | None | 13 (9‐24) | 2 (40%) | 0 |
Abbreviation: NA, not available.